胱蛋白酶抑制剂C和内生肌酐清除率与肾脏病理变化的关系探讨

目的　了解血胱蛋白酶抑制剂 (cystatin)C和内生肌酐清除率 (Ccr)与肾脏病理变化的关系。 方法　选择 1999年 1月～ 2 0 0 3年 2月因各种肾脏疾病收治入院行肾穿刺活检术的患儿共 12 4例 ,入院后查血cys tatinC和Ccr ,并行肾穿刺活检术以了解肾脏病理变化 ,然后通过相关及多元线性回归分析了解血cystatinC和Ccr与肾脏病理变化的关系。结果　血cystatinC与肾脏病理变化的复相关系数 (R) =0 .6 91(P <0 .0 1) ,血cys tatinC与肾脏病理变化之间存在直线关系 ,其回归方程为Y =0 .6 0 5 +0 .30 7X1+0 .4 93X2 (F =5 5 .18,P <0 .0 1)。Ccr与肾脏病理变化的R =0 .4 0 5 (P <0 .0 1) ,Ccr与肾脏病理变化之间亦存在直线关系 (F =11.89,P<0 .0 1)。结论　血cystatinC比Ccr更能反映肾脏病理变化的严重程度。血cystatinC和Ccr均与肾间质的变化密切相关 ,尤以血cystatinC更敏感。因此 ,血cystatinC可作为判断肾脏疾病预后的重要参考指标 ,以及时了解肾脏病理变化采取有效的治疗。     

Obesity in Diabetic Patients Undergoing Coronary Artery Bypass Graft Surgery Is Associated with Increased Postoperative Morbidity

Background: Despite the fact that obesity is a known risk factor for cardiovascular disease, many studies have failed to demonstrate that obesity is independently associated with an increased risk of cardiovascular morbidity and mortality in nondiabetic patients undergoing coronary artery bypass graft surgery. The authors investigated the influence of obesity on adverse postoperative outcomes in diabetic and nondiabetic patients after primary coronary artery bypass surgery.

Methods: A retrospective cohort study of patients undergoing primary coronary artery bypass surgery (n = 9,862) between January 1995 and December 2004 at the Texas Heart Institute was performed. Diabetic (n = 3,374) and nondiabetic patients (n = 6,488) were classified into five groups, according to their body mass index: normal weight (n = 2,148), overweight (n = 4,257), mild obesity (n = 2,298), moderate obesity (n = 785), or morbid obesity (n = 338). Multivariate, stepwise logistic regression was performed controlling for patient demographics, medical history, and preoperative medications to determine whether obesity was independently associated with an increased risk of adverse postoperative outcomes.

Results: Obesity in nondiabetic patients was not independently associated with an increased risk of adverse postoperative outcomes. In contrast, obesity in diabetic patients was independently associated with a significantly increased risk of postoperative respiratory failure (odds ratio [OR], 2.26; 95% confidence interval [CI], 1.41-3.61; P < 0.001), ventricular tachycardia (OR, 2.27; 95% CI, 1.18-4.35; P < 0.02), atrial fibrillation (OR, 1.56; 95% CI, 1.03-2.38; P < 0.04), atrial flutter (OR, 2.38; 95% CI, 1.29-4.40; P < 0.01), renal insufficiency (OR, 1.66; 95% CI, 1.10-3.41; P < 0.03), and leg wound infection (OR, 5.34; 95% CI, 2.27-12.54; P < 0.001). Obesity in diabetic patients was not independently associated with an increased risk of mortality, stroke, myocardial infarction, sepsis, or sternal wound infection.     

在音乐缭绕中痊愈

你是否曾经因为它血脉贲张浑身发抖过．你是否因为它心潮起伏热泪盈眶过？如果这世界上没有它．你怕么？当天堂的圣歌响起．即使面对死亡．你也无所畏惧，它以它温柔的手．抚平你心里和肉体的伤……它让你不痛。[编者按]     

BDNF基因修饰神经干细胞移植后大鼠脊髓损伤移植处的基因表达变化

目的：了解脑源性神经营养因子（Brain-derived neurotrophic factor,BDNF）基因修饰神经干细胞移植到大鼠脊髓损伤处后的基因表达变化，为脊髓损伤修复提供基础研究资料。方法：大鼠随机分为4组：正常对照组，手术对照组，神经干细胞（Neural stem cells,NSCs）移植组，BDNF－NSCs移植组，各组分4个时相点（7d、1个月、2个月、3个月），利用细胞移植、X-gal组化、免疫组化、原位杂交等方法，观察了移植处细胞的标记基因（LacZ）表达和BDNF、胶质纤维酸性蛋白（GFAP）、神经丝－200（NF－200）的表达。结果：大鼠脊髓损伤移植处细胞中，有标记基因阳性细胞，BDNF强烈表达，尤其是BDNF－NSCs移植组的移植后1周和1个月时。各组各时相点均有GFAP和NF－200免疫反应阳性细胞和纤维。结论：BDNF基因修饰神经干细胞能在脊髓损伤移植处存活，强烈表达BDNF，BDNF基因修饰神经干细胞可以作为脊髓损伤修复的移植材料。     

含碘食物对Graves病患者甲状腺^131I与^99mTc摄取的不同影响

目的 探讨含碘食物对Graves病患者摄取^99mTc与^131I的影响。方法 选择曾食含碘食物的Graves病患者20例，在禁食含碘食物前后分两次进行摄^131I试验与甲状腺^99mTc显像．前者测定3、24h摄^131I率，后者计算摄锝指数(TI)及估算甲状腺质量(TW)。采用Wilcoxon符号秩和检验对数据进行对比分析。结果 20例患者禁止含碘食物前后的摄^131I率显著不同，所有患者禁食含碘食物后3和24h摄^131I率均显著增高。TI2例未变、2例增高、16例降低；TM18例减小、2例增大。较未禁食含碘食物的首次检测，两者均有显著性变化。结论 含碘食物对甲状腺摄取Na^99mTcO4的影响与Na^131I显著不同，含碘食物100％减低甲状腺^131I的摄取而90％锝摄取增高。     

传染性非典型肺炎患者泪液和血液中特异性抗体检测的对比研究

目的：通过传染性非典型肺炎(SARS)患者泪液病毒特异性抗体的检测，寻找SARS病毒是否通过泪液或眼结膜传播的理论依据，了解泪液和血液中SARS病毒特异性抗体检测结果的一致性程度。方法：用酶联免疫吸附法(ELISA)检测18例不同病程的SARS患者泪波及血清SARS病毒特异性抗体。结果：18例SARS患者泪液中的特异性IgM类和IgG类抗体均为阴性，而同组患者有13例其血液中的特异性IgM类和IgG类抗体呈阳性。结论：SARS病毒可能不通过泪液或结膜传播。     

高血压合并阻塞性睡眠呼吸暂停的短期血压变异性研究

目的 比较高血压合并阻塞性睡眠呼吸暂停患者的短期血压变异性。方法 将155例分为对照组、高血压组、高血压合并轻度或中重度阻塞性睡眠呼吸暂停组，EE较患者不同活动状态的短期血压变异性。结果 高血压合并中重度阻塞性睡眠呼吸暂停组患者睡眠期间和早晨血压变异系数分别为：收缩压18．69、21．32；舒张压19．41、23．61，明显高于其他各组。结论 夜间睡眠期间和早晨短期血压变异性增加，是高血压合并中重度阻塞性睡眠呼吸暂停患者夜间和早晨心血管事件发生率增加的重要危险因素。     

A preliminary study of the relationship between antibiotic administration and changes in bacteriological profile of wound infection in a burn unit

Objective:To investigate the relationship between antibiotic administration and the changes in bacteriological profile in a burn unit. Methods: The data of consumption of different kinds of antibiotics, including total antibiotic consumption [expressed as the number of defined daily doses (DDD)] as well as pathogen identification, were collected in a 8-year period. The constituent ratios of different kinds of antibiotics in total antibiotic consumption to isolation rates of various species of bacteria were calculated, and their correlation was analyzed. Results: Within this period, it was found that the aminoglycosides and first generation cephalosporins were used less frequently, while the polypeptides, carbopenem and macrolides were used proportionally more. At the same time, the isolation rates of Staphylococcus aureus, Acinetobacter sp, Enterobacter cloacae, Klebsiella pneumoniae and methicillin-resistant Staphylococcus aureus were gradually increased. The constituent ratios of predominant pathogens were correlated to the different kinds of antibiotics consumption in the burn unit. Conclusion: The results suggested that the consumption of different antibiotics was closely related to the trends of emergence of bacterial isolates from infected burn wounds. The result might imply that to regulate the administration of certain antibiotics might help decrease the emergence of certain pathogenic bacteria in burn infections.     

血管紧张素Ⅱ2型受体研究进展

血管紧张素Ⅱ作为肾素-血管紧张素系统的主要活性肽,根据其与肽类和非肽类的选择性亲和力可分为两个亚型,分别命名为AT1-R和AT2-R。AT1-R可被特异的非肽类拮抗剂所阻断,如沙坦类;AT2-R拮抗剂包括非肽类化合物PD 123317和PD 123319,还有一部分AT2-R的配体是肽类激动剂,如CGP 4221等,这些肽类配体在炎症过程中也可以和非血管紧张素位点结合〔1〕。AT1-R在调节心血管效应、体液和电解质的平衡、激素释放和饮水行为方面的作用已被确认,部分AT1-R拮抗剂已经用于高血压的治疗,而AT2-R的生理功能尚不清楚。1 AT2-R的结构AT2-R分子结…     

β-catenin基因第3外显子突变及蛋白异常表达与胰腺实性-假乳头状瘤发生的关系

目的研究Wnt信号中β-catenin基因第3外显子突变及蛋白异常表达在胰腺实性-假乳头状瘤（SPTs）发生中的作用。方法①对15例SPTs石蜡包埋组织进行DNA提取，PCR扩增，PCR产物纯化、测序，对β-catenin基因第3外显子进行突变分析。②采用免疫组化PV6000法检测SPTs组织中β-catenin蛋白的表达。结果①β-catenin基因第3外显子在15例SPTs组织中有12例发生了一个碱基的错义突变，突变率为80．0％，表现在密码子32位（5例）、33位（3例）和37位（4例）。②15例SPTs组织中有13例β-catenin蛋白呈细胞核表达，异常表达率为86．7％。结论Wnt信号中β-catenin基因突变及蛋白核内聚集在SPTs发生中起重要作用。